Evidence map›Paper›PMID 32326286›Full record

ArticlePharmaceutics2020

Spatially Resolved Effects of Protein Freeze-Thawing in a Small-Scale Model Using Monoclonal Antibodies.

Oliver Spadiut, Thomas Gundinger, Birgit Pittermann, Christoph Slouka

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Oliver SpadiutResearch Division Biochemical Engineering, Group for Integrated Bioprocess Development, Institute of Chemical Environmental and Bioscience Engineering, Vienna University of Technology, 1060 Vienna, Austria.ORCID 0000-0003-0916-0644
Thomas GundingerResearch Division Biochemical Engineering, Group for Integrated Bioprocess Development, Institute of Chemical Environmental and Bioscience Engineering, Vienna University of Technology, 1060 Vienna, Austria.
Birgit PittermannHead of R&D, ZETA GmbH, Zetaplatz 1, A-8501 Lieboch, 8501 Graz, Austria.
Christoph SloukaResearch Division Biochemical Engineering, Group for Integrated Bioprocess Development, Institute of Chemical Environmental and Bioscience Engineering, Vienna University of Technology, 1060 Vienna, Austria.ORCID 0000-0002-8627-295X
TU Wien · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein freeze-thawing is frequently used to stabilize and store recombinantly produced proteins after different unit operations in upstream and downstream processing. However, freeze-thawing is often accompanied by product damage and, hence, loss of product. Different effects are responsible, including cold denaturation, aggregation effects, which are caused by inhomogeneities in protein concentration, as well as pH and buffer ingredients, especially during the freeze cycle. In this study, we tested a commercially available small-scale protein freezing unit using immunoglobin G (IgG) as monoclonal antibody in a typical formulation buffer containing sodium phosphate, sodium chloride, and Tween 80. Different freezing rates were used respectively, and the product quality was tested in the frozen sample. Spatially resolved tests for protein concentration, pH, conductivity, and aggregation revealed high spatial differences in the frozen sample. Usage of slow freezing rates revealed high inhomogeneities in terms of buffer salt and protein distribution, while fast rates led to far lower spatial differences. These protein and buffer salt inhomogeneities can be reliably monitored using straight forward analytics, like conductivity and photometric total protein concentration measurements, reducing the need for HPLC analytics in screening experiments. Summarizing, fast freezing using steep rates shows promising results concerning homogeneity of the final frozen product and inhibits increased product aggregation.

Indexed as

freeze-thawingfreezing rateice formation ratemonoclonal antibody

Identifiers

PMID32326286
PMCPMC7238022
OpenAlexW3018961066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.